Dr. Mark Sandrik

D.D.S. | Dentist



  
  6234 S Narragansett Ave, Chicago
  Illinois, 60638-4233

  773-586-3456    773-586-1277 Maps & Directions
Dr. Mark Sandrik is a Chicago, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 6234 S Narragansett Ave, Chicago. Patients can reach him at 773-586-3456.
Dr. Mark Sandrik is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Mark Sandrik speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Mark Sandrik
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:6234 S Narragansett Ave, Chicago,
Illinois, 60638-4233
Phone:773-586-3456
Fax:773-586-1277
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7719289131
Enrollment ID: I20151231000849
NPI Number: 1811032758
NPI Enumeration Date: 20 Feb, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 205 Michaux Rd,
Riverside, Illinois
Zip: 60546-1829
Phone Number: 708-447-1340
Patients can reach Dr. Mark Sandrik at 6234 S Narragansett Ave, Chicago, Illinois or can call to book an appointment on 773-586-3456. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: